These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27770803)

  • 1. The response of mute swans (Cygnus olor, Gm. 1789) to vaccination against avian influenza with an inactivated H5N2 vaccine.
    Dolka B; Żbikowski A; Dolka I; Szeleszczuk P
    Acta Vet Scand; 2016 Oct; 58(1):74. PubMed ID: 27770803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
    Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine.
    Philippa J; Baas C; Beyer W; Bestebroer T; Fouchier R; Smith D; Schaftenaar W; Osterhaus A
    Vaccine; 2007 May; 25(19):3800-8. PubMed ID: 17403559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.
    Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Safwat M; Nawar AA; Erfan AM; Hassan MK; Aly MM; Hafez HM
    Vet Microbiol; 2011 May; 150(1-2):28-34. PubMed ID: 21236607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vaccine; 2011 Aug; 29(37):6219-25. PubMed ID: 21745517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic response and safety to vaccination against avian influenza using inactivated H5N2 vaccine in zoo birds.
    Lécu A; De Langhe C; Petit T; Bernard F; Swam H
    J Zoo Wildl Med; 2009 Dec; 40(4):731-43. PubMed ID: 20063820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.
    Abdelwhab EM; Grund C; Aly MM; Beer M; Harder TC; Hafez HM
    Vet Microbiol; 2012 Feb; 155(1):13-20. PubMed ID: 21920677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus.
    Swayne DE; Lee CW; Spackman E
    Avian Pathol; 2006 Apr; 35(2):141-6. PubMed ID: 16595307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.
    Swayne DE; Pavade G; Hamilton K; Vallat B; Miyagishima K
    Rev Sci Tech; 2011 Dec; 30(3):839-70. PubMed ID: 22435196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR; Pantin-Jackwood MJ; Spackman E; Chrzastek K; Suarez DL; Swayne DE
    Vaccine; 2017 Nov; 35(46):6345-6353. PubMed ID: 28456525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of avian influenza vaccination in Hong Kong.
    Ellis TM; Sims LD; Wong HK; Wong CW; Dyrting KC; Chow KW; Leung C; Peiris JS
    Dev Biol (Basel); 2006; 124():133-43. PubMed ID: 16447504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral antibody responses to different H5N1 and H5N2 vaccination regimes: implications for the development of autogenously based vaccines.
    Shany SA; El-Kady MF; Eid BT; Hassan ER; Abdel-Moneim AS
    Vet Microbiol; 2011 Dec; 153(3-4):398-402. PubMed ID: 21752557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequence of Cryptosporidiosis on the immune response of vaccinated broiler chickens against Newcastle disease and/or avian influenza.
    Eladl AH; Hamed HR; Khalil MR
    Vet Res Commun; 2014 Sep; 38(3):237-47. PubMed ID: 24993748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virus.
    Kapczynski DR; Sylte MJ; Killian ML; Torchetti MK; Chrzastek K; Suarez DL
    Vet Immunol Immunopathol; 2017 Sep; 191():74-79. PubMed ID: 28895870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus.
    Hussein HA; Ahmed BM; Aly SM; El-Deeb AH; El-Sanousi AA; Rohaim MA; Arafa AA; Gadalla MR
    Acta Virol; 2016; 60(3):307-15. PubMed ID: 27640441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Pathogenic and Low Pathogenic Avian Influenza H5 Subtype Viruses in Wild Birds in Ukraine.
    Muzyka D; Rula O; Tkachenko S; Muzyka N; Köthe S; Pishchanskyi O; Stegniy B; Pantin-Jackwood M; Beer M
    Avian Dis; 2019 Mar; 63(sp1):235-245. PubMed ID: 31713401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Pathogenic and Low Pathogenic Avian Influenza H5 Subtype Viruses in Wild Birds in Ukraine.
    Muzyka D; Rula O; Tkachenko S; Muzyka N; Köthe S; Pishchanskyi O; Stegniy B; Pantin-Jackwood M; Beer M
    Avian Dis; 2019 Mar; 63(sp1):219-229. PubMed ID: 31131580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse genetics based rgH5N2 vaccine provides protection against high dose challenge of H5N1 avian influenza virus in chicken.
    Bhatia S; Khandia R; Sood R; Bhat S; Siddiqui A; Jahagirdhar G; Mishra S; Mishra A; Pateriya AK; Kulkarni DD
    Microb Pathog; 2016 Aug; 97():172-7. PubMed ID: 27296706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Santos JJS; Obadan AO; Garcia SC; Carnaccini S; Kapczynski DR; Pantin-Jackwood M; Suarez DL; Perez DR
    Vaccine; 2017 Oct; 35(42):5637-5643. PubMed ID: 28886943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.